Mark Bachleda - 16 Mar 2023 Form 4 Insider Report for Galera Therapeutics, Inc. (GRTX)

Role: Chief Commercial Officer
Signature: /s/ Chris Degnan, Attorney-in-Fact for Mark Bachleda
Issuer symbol: GRTX
Transactions as of: 16 Mar 2023
Net transactions value: +$24,717
Form type: 4
Filing time: 20 Mar 2023, 16:05:17 UTC
Previous filing: 28 Feb 2023
Next filing: 11 Jun 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GRTX	Common Stock	Purchase	$24,717	+11,000		$2.25^*	11,000	16 Mar 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.21 to $2.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.21 to $2.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.